Twist Bioscience (TWST) Income from Continuing Operations (2017 - 2025)

Twist Bioscience (TWST) has disclosed Income from Continuing Operations for 9 consecutive years, with 30507000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 3.44% to 30507000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 76608000.0 through Dec 2025, up 61.16% year-over-year, with the annual reading at 77670000.0 for FY2025, 62.8% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 30507000.0 at Twist Bioscience, down from 27138000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 20390000.0 in Q2 2025, with the low at 85571000.0 in Q2 2024.
  • Average Income from Continuing Operations over 5 years is 42931800.0, with a median of 42416000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations crashed 69.59% in 2021, then surged 123.83% in 2025.
  • Over 5 years, Income from Continuing Operations stood at 45563000.0 in 2021, then rose by 8.21% to 41824000.0 in 2022, then decreased by 2.83% to 43008000.0 in 2023, then increased by 26.54% to 31594000.0 in 2024, then increased by 3.44% to 30507000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 30507000.0, 27138000.0, and 20390000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.